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Aim: To measure the health related quality of life (HRQoL) among Saudi Arabian adolescents
with type 1 diabetes mellitus (T1DM) and the impact the disease has on the family.
Methodology: A cross sectional study was conducted involving 315 adolescent patients (12–
18 years) and their caregivers. Adolescent HRQoL was assessed by adolescents and their
parents completing the Peds QLTM Diabetes Module 3.0. Family impact was assessed by the
parent completing the Peds QLTM Family Impact module (FIM).
Results: Adolescents reported a cumulative mean HRQoL score of 64.8, while parents
reported significantly lower scores of 60.3 ( p = 0.003). The lowest scores reported by both
adolescents and parents were for ‘‘Worry’’. Female gender and late adolescent age were
predictors of lower HRQoL for adolescents with T1DM. The FIM showed low scores for
‘‘Emotional functioning’’ (59.8) and high scores for ‘‘Family relationships’’ (80.9).
Conclusion: These findings emphasize the importance of an interdisciplinary, biopsycho-
social and family centered care approach to adolescents with a chronic disease. Future work
could assess the effectiveness of direct care involvement of adolescent and mental health
experts in improving the HRQoL for this population.
# 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Diabetes is a global epidemic with 382 million people affected
by the disease worldwide and with figures expected to rise to
582 million by 2035 [1]. In Saudi Arabia, diabetes remains a
major public health problem affecting 24% of the population.
Furthermore, the burden of type 1 diabetes (T1DM) among
children and adolescents in the country has more than* Corresponding author at: King Abdullah Specialized Children’s Ho
Tel.: +966118011111x53551
E-mail address: buhairanfs@ngha.med.sa (F. AlBuhairan).
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0168-8227/# 2016 The Authors. Published by Elsevier Ireland Ltd. This
creativecommons.org/licenses/by-nc-nd/4.0/).doubled in the past decade with average incidence rates
reported at 27.2/100,000 population [2]. T1DM is defined as a
metabolic disease characterized by chronic hyperglycemia
resulting from absolute insulin deficiency and requiring
lifelong insulin replacement therapy [3]. Living with T1DM
presents numerous daily challenges associated with disease
management to both the adolescent and family and includes
such challenges as: intensive therapeutic insulin regimes
(daily injections or pump adjustments), need for dietaryspital P.O. Box 22490, Mail Code 1940. Riyadh 11426, Saudi Arabia.
 is an open access article under the CC BY-NC-ND license (http://
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biochemical markers [4].
Traditionally, the mainstay of T1DM management has
focused on achieving good metabolic (glycemic) control in
order to prevent the long-term complications of the disease.
Medical practice has shifted, recognizing the importance of
treating all dimensions of patient health and not merely the
clinical parameters or markers of disease [5]. As such, more
attention has been given to assessing and addressing the
health related quality of life (HRQoL) of patients. Although
there is no universal definition for HRQoL, it broadly describes
the impact of an individual’s health status on their quality of
life in terms of physical, psychological (emotional and
cognitive), and social functioning [6]. It has been recom-
mended that part of the process of improving health care
includes regularly measuring HRQoL outcomes [7,8]. The
HRQoL of children and adolescents with T1DM has been
reported by both children and their parents to affect several
domains, including school functioning, emotional well-being,
and physical and social aspects [9]. Furthermore, HRQoL has
been reported to be lower in T1DM children and adolescents
compared to healthy counterparts [10]. Adolescents in
particular are known to have unique needs based on the
significant developmental changes that occur during this
transitional period in life [11].
Among patients with T1DM, it has been reported that
adolescents have the poorest HRQoL [12–14]. They have been
found to have more psychological problems with significant
increase risk of depression [8,15,16]. Metabolic control in
adolescents with diabetes tends to be poor because of the
often challenging necessary lifestyle adjustments required to
manage the disease in combination with hormonal and
psychosocial changes that occur during this transitional
period [17,18]. Knowledge of the HRQoL of adolescents based
on the assessment of different domains allows health care
providers to tailor their management to meet the individual
needs of the adolescent patient [15].
T1DM is often considered to be a disease of the family
rather than just the individual affected, due to the integral
‘‘role of family relationships and parental support’’ [19].
Parental reporting of HRQoL is considered important given
the young age of patients. Furthermore, studies suggest that
taking the parental perspective particularly adds to informa-
tion gained about the psychological component of HRQoL
assessment of youth [20,21]. Studies have reported association
between poor adolescent glycemic control with poor adoles-
cent self management which results in high levels of family
conflict and distress. Scientific literature reports a negative
association between parents who are less responsive toward
their adolescent (communication of affection), over reactive in
discipline, have low family income and high levels of parental
depression with metabolic control and HRQoL for their
adolescent with T1DM [19].
Although HRQol in T1DM adolescents has been looked at in
many countries, in Saudi Arabia to date, only one hospital
based study has been conducted (reporting HRQoL from the
teen’s perspective alone) [22]. To gain more information and a
better understanding of factors affecting HRQoL for adoles-
cents with T1DM in Saudi Arabia, this study aims to measure
the HRQoL of adolescents with T1DM from both the adolescentand parental perspective. In addition, the impact of the
chronic illness on the family will be assessed.
2. Research design and methods
2.1. Study design and settings
This cross-sectional study was carried out during 2012–13 at
three of the Ministry of National Guard-Health Affairs (MNGHA)
affiliated hospitals in Saudi Arabia following approval by the
institutional ethics committee. The MNGHA hospitals are
academic hospitals that provide secondary and tertiary care
to employees of the National Guard and their dependents.
These hospitals also serve as national referral centers for
certain chronic disease, including T1DM. The three hospitals
are located in Central, Western, and Eastern regions and are
among the largest government hospitals in the country.
2.2. Population sample
Participants were recruited from the outpatient clinics at the
hospital. Adolescent patients aged 12–18 years and known to
have T1DM for at least 1 year were eligible to participate. These
subjects along with their parents/caregivers were invited to
participate in the study. Participants were recruited by a
research assistant who met with the patient and his/her
parent/caregiver. A verbal description in addition to written
information about the study was provided before written
informed consent was obtained to participate in the study.
2.3. Data collection
Demographic and background clinical information on the
patient’s course of disease, e.g. HbA1C level, method and
administrator of insulin delivery, and co morbidities were
collected. SES was determined by parental education. Good
SES was based on paternal or maternal attainment of post-
secondary school education, i.e. completing diploma, univer-
sity or postgraduate education. Poor SES was based on father
or mother completing secondary, intermediate, or primary
education or being uneducated. Thereafter, both adolescent
and parent/caregiver independently completed the Peds QLTM
Diabetes Module ‘teen report’ and ‘parent for teen report’
respectively. Parents/caregivers were also requested to com-
plete the family impact module.
2.3.1. Data collection instruments
Two instruments were adopted and used in this study. The
Pediatric Quality of Life Inventory (Peds QLTM) Diabetes
Module 3.0 and [9] Family Impact module [23] were used with
permission. Both instruments underwent forward (into Ara-
bic) and backward translation and were tested prior to their
use in this study. The final Arabic versions of the modules can
be found online [24].
The first instrument was developed specifically to assess
HRQoL for children and adolescents with T1DM. It is
multidimensional and contains 5 assessment scales: diabetic
symptoms; treatment barriers; treatment adherence; worry;
and communication and is measured on a 5-Likert point scale
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and ‘parent report for teen’ versions of this scale were
answered by the adolescent patient and parent/caregiver
respectively. The two versions are very similar with the latter
providing a proxy measure of the adolescent’s HRQoL as
viewed by the parent/caregiver.
The second instrument, the Peds QLTM Family Impact
module, assesses the impact of the child’s disease on the
family. It is a 36-item questionnaire that has eight scales. The
scales assess: physical; emotional; social functioning; cogni-
tive functioning; communication; worry; daily activities; and
family relationships. Again each scale is measured using the
same Likert scale coding. Parents/caregivers were requested to
respond to this instrument.
Two additional scores were calculated from the scales
assessed by the family impact instrument: (1) Parental
functioning score: which is an aggregate average of the
physical, emotional, social and cognitive functioning scales,
and (2) Family functioning score which is an aggregate average
of the daily activities and family relationships scales (see
Table 2).
2.3.2. Validation of the instruments
The Peds QLTM instruments used in the study were initially
translated into Arabic and validated on a sample of 10
participants. The translation included a forward and back-
ward translation. Thereafter, it was tested on a sample of
individuals to assess for reliability and validity. The summa-
tion of scores and sub scale scores was assessed for internal
consistency reliability using Cronbach’s a coefficient. In
addition Test re-test reliability of the Arabic Peds QLTM was
determined by Cohen’s Kappa coefficient. For both instru-
ments, a scoring algorithm was used to reverse the 0–4 scale
scores and linearly transform them on a 0–100 scale so that
0 = 100 and 4 = 0. The scoring transformation translates to
better quality of life in those who achieved higher scores [9].
2.4. Statistical analysis
Univariate descriptive analysis was carried out to summarize
the demographic and clinical characteristics of adolescent
diabetic patients. Categorical variables were reported as count
and percent n (%), while continuous variables were summa-
rized as mean and standard deviation. Wilcoxon Mann
Whitney test was used to compare HRQoL scores reported
by adolescents to those reported by parents/caregivers. Two
generalized linear models were employed to identify potential
covariates of teen’s quality of life and family functioning score
respectively. The covariates, limited to gender, age, socioeco-
nomic status (SES), comorbidities, disease duration and
treatment modality were analyzed by the model. Data was
analyzed using SAS version 9.4 (SAS Institute Inc., Cary, NC).
3. Results
3.1. Demographics
All of the patients and parents/caregivers who were invited to
take part in the study agreed to participate, giving a 100%response rate. A total of 315 subjects with T1DM participated.
A gender distribution of 132 (41.9%) males vs. 183 (58.1%)
females was represented in the study sample. The mean age of
adolescents was 15.1  0.1 years. Eleven percent had a
comorbid health condition. Most of the adolescent partici-
pants lived with both parents and the majority had stay at
home mothers, n = 245 (78.27%). Nearly 40% of mothers had
either a primary school education or were uneducated, 34%
had been to secondary school, and only 25% had a college
diploma or university education. In comparison, paternal
education level was higher with 30% of fathers holding a
diploma/university education and 1.61% of fathers holding a
postgraduate education.
3.2. Diabetes and control
The average duration of diabetes illness was 6.9  3.8 years.
Overall, diabetes was poorly controlled among participants
with the mean HbA1C = 10.1  1.2% (87  10 mmol/mol). Insu-
lin was administered through multiple daily injections (MDIs)
by the majority of adolescents (76.4%), whereas 20.1% used a
pump, and 3.5% used a conventional twice daily insulin
injection. The majority of participants (79.1%) self-adminis-
tered their insulin.
3.3. Adolescents’ health related quality of life
Table 1 summarizes the HRQoL of adolescents diagnosed with
T1DM as reported by the teens and their parents. The average
total scale score of the teen’s report was 64.8 (95% CI 62.9–66.6),
whereas the average total score of parents’ report for teens
was significantly lower at 60.3 ( p = 0.0003). Parents consis-
tently reported lower scores for teens’ HRQoL than teens
reported themselves. Though there were significant differ-
ences between teens’ and parents’ reports for ‘‘Treatment
adherence’’ and ‘‘Worry’’, both teens’ and parents’ individual
scores for these two subscales were similar in the sense that
they were the highest and lowest subscale scores respectively.
Gender and age were the statistically significant predictors
impacting teens’ quality of life. Females had lower QoL scores
compared to males ( p < .0001), and younger adolescents aged
13–15 years had higher QoL scores compared to older
adolescents aged 16–18 years ( p < 0.0002).
3.4. Family impact scores among adolescents with T1DM
Table 2 summarizes the distribution of family impact scores
reported by parents. The average total scale score for family
impact was 67.4 (95% CI 65.3–69.5). ‘‘Worry’’ was also reported
to have the lowest score among all subscales in the family
impact score. Highest subscale score was reported for family
relationships (Table 3).
3.5. Discussion
Increasingly, pediatric and adolescent medical practice is
recognizing the importance of incorporating disease specific
HRQoL assessment of patients as part of a more holistic
approach to disease management [5]. To date, scientific
studies have repeatedly demonstrated that adolescents
Table 2 – Family impact scores reported by parents of teens with T1DM.
Peds QLTM FIM scales Average scores 95% CI (lower, upper)
Mean SE
Total scale score 67.39 1.05 65.31, 69.47
Parental functioning score 66.72 1.17 64.41, 69.02
Family functioning score 73.07 1.28 70.54, 75.61
Physical functioning 64.07 1.27 61.57, 66.57
Emotional functioning 59.8 1.58 56.68, 62.91
Social functioning 76.05 1.45 73.20, 78.91
Cognitive functioning 73.02 1.41 70.21, 75.78
Communication 78.43 1.52 75.42, 81.43
Worry 42.08 1.73 38.66, 45.50
Daily activities 65.05 1.65 61.80, 68.31
Family relationships 80.9 1.29 78.34, 83.46
Table 1 – Comparison of adolescents’ and parents’ reports of adolescent HRQoL.
Peds QLTM Diabetes Module scales Teen report Parent report for teen Difference 95% CI (lower, upper) p-value
Total scale score 64.78 60.33 4.53 2.22, 6.85 0.0003
About my Diabetes 61.98 61.43 0.64 1.57, 2.86 0.463
Treatment barriers 62.79 61.93 0.6 2.58, 3.79 0.606
Treatment adherence 72.81 65.46 7.24 4.22, 10.26 <0.0001
Worry 55.42 50.31 5.33 1.15, 9.50 0.034
Communication 70.72 62.58 8.57 3.94, 13.21 0.004
Table 3 – Predictors of adolescents’ HRQoL.
Parameter Predictor Estimate Standard error 95% CI (lower, upper) p-value
Intercept 80.02 6.51 67.27, 92.79 <.0001
Gender Female vs. male 8.41 2.03 12.40, 4.43 <.0001
SES Poor vs. good 0.13 1.97 3.73, 3.99 0.9471
Comorbidities Yes vs. no 1.14 3.04 7.10, 4.81 0.7068
Age Older vs. younger 7.62 2.02 11.58, 3.67 0.0002
Disease duration 0.01 0.27 0.54, 0.52 0.9705
Treatment modality MDI vs. conventional 8.47 6.20 20.62, 3.69 0.1721
Treatment modality Pump vs. conventional 0.71 6.58 13.60, 12.18 0.9138
McFadden pseudo R2 = 2%.
SES: socioeconomic status; MDI: multiple daily injections.
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[25,26], epilepsy [27], obesity [27], rheumatoid arthritis [28],
and sickle cell disease [28] have poorer quality of life
indicators compared to healthy controls. This finding is also
apparent in literature comparing HRQoL in adolescents with
T1DM [9,29–32].
The Peds QLTM Diabetes Module has been used in a number
of studies among adolescents with T1DM conducted in the
Middle East [22,29,30], Europe [31,33–35], and the United States
(US) [9]. Although these studies are not nationally representa-
tive of the population of adolescents with T1DM in each
country, valuable insight into HRQol for adolescents with
T1DM for each country can be gained. HRQoL has been
reported to range between 59.2 and 73.8 in other countries,
with the lowest overall scores found in Iran and Greece, and
the highest scores in Sweden and Italy and the US [9,33,35].
The diabetic teens in Saudi Arabia reported lower individual
and total scale scores compared to diabetic teens in several
other countries (Table 4). The ‘‘About my Diabetes’’ subscale
score, however, was found to be the lowest in these countries[9,29,33–35], in contrast to the ‘‘Worry’’ subscale being the
lowest for adolescents in our study.
Furthermore, the ‘‘Worry’’ subscale score in our study is the
lowest reported score among all countries reviewed (Table 4). These
findings corroborate the low Worry HRQoL scores reported by
T1DM teens in another study in the country [22].
The reasons as to why the Worry domain scored the lowest
is unclear. The domain related to poor diabetic control (About
my Diabetes) was the second lowest score among all domains
for our adolescents and may therefore be related to the worry
that adolescents have been experiencing. This is consistent
with other studies that have shown that poor glycemic control
predicts worry and adolescent diabetes distress [17] and
negatively affects quality of life in diabetic sufferers [36].
Similarly, the psychological belief of being able to cope with
disease has been shown to improve self-care among adoles-
cent diabetes sufferers and reduce levels of depression and
anxiety [36].
Furthermore, current medical practice in Saudi Arabia
tends to primarily focus on achieving metabolic control,
Table 4 – Comparison of HRQoL scores among adolescents with T1DM in Saudi Arabia with HRQoL from other countries.
Country About my
Diabetes
Treatment
barriers
Treatment
adherence
Worry Communication Total scale
score (SE)
95% CI
(lower, upper)
Age range
(years)
Sample
size
Saudi Arabia 61.98 62.79 72.81 55.42 70.72 64.78 (0.94) 62.9, 66.9 12–18 315
US (9) 65.31 73.72 80.81 71.54 74.07 72.01a 5–18 300
Sweden (33) 65.9 77 82.8 82.5 71.5 73.8 (12.5) 49.3, 98.3 5–18 108
Italy (35) 64.69 79.22 82.35 66.91 73.42 73.32 (13.07) 47.7, 98.9 5–18 169
Hungary (34) 63.77 69.51 82.53 69.17 77.36 71.38 (12.71) 46.5, 96.3 8–18 355
Kuwait (29) 63.4 70.3 76.6 69.9 75.3 70.2 (9.8) 51.0, 89.4 2–18 377
Greece (31) 59.91 59.56 64.79 61.19 58.49 61.07 (13.43) 33.9, 86.5 5–18 117
Iran (30) 59.21 58.38 60.18 56.47 61.08 59.24b 8–18 94
a, b SE for total scale score were not available.
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is paid on addressing the psychosocial components of disease
management and the impact it has on adolescents’ HRQoL.
This may partly explain why the worry score for HRQoL was so
low. However, further studies are needed to confirm and
compare whether the overall approach to care for adolescents
with type 1 diabetes differs in Saudi Arabia as compared to
other countries where scores reported for Worry are much
higher.
In addition, good diabetes management is dependent on
healthy lifestyle factors, including diet and physical exercise.
Unhealthy lifestyle factors, particularly unhealthy diet and
sedentary lifestyle with little physical activity are noted to be
common behaviors among adolescents in Saudi Arabia [37].
These behaviors may act as barriers to achieving good diabetes
management [38] and contribute to anxiety and worry about
the disease.
Our study showed that gender and age were statistically
significant predictors of teen QoL. Females reported lower QoL
scores compared to males. This is a consistent finding
reported both within the country and afar [22,36,39]. Though
unclear why females have lower HRQoL compared to males,
possible reasons include the different physical and hormonal
changes that occur during puberty between the sexes: girls
have higher insulin requirements during puberty [40]. Female
adolescents with T1DM are known to have more unhealthy
weight control practices, such as skipping or taking less
insulin compared to males resulting in poor metabolic control
[36] which is itself associated with reduced quality of life.
Studies have also shown that female adolescents reported low
QoL scores attributed to having more diabetes related worries
and less overall satisfaction with life compared to males
[36,41]. Furthermore, recent evidence has shown that female
adolescents in Saudi Arabia have double the prevalence rates
of depression as compared to males [37].
Our study showed that teens in early adolescence (13–15
years) had better QoL compared to teens in later years of
adolescence (16–18 years). Teens in the later stages of
adolescence may assume greater autonomy in handling their
insulin regime, with less parental influence compared to
younger adolescents. Several studies have shown that ‘‘self
care autonomy and reduced parental involvement predict
poorer self-care management’’ [39] and poor management of
their diabetes has been associated with poor quality of life.
The results also show that there is discordance in HRQoL
reporting across all scales between teens and their parents,with parents reporting lower scores than their teen. In fact,
studies across the Middle East [29,30], and further afield [9,31]
have often reported parents do not necessarily concur with the
perspectives of their child with relation to their illness, with
parents often reporting lower HRQoL for their children
suffering from the disease. A recent study in Kuwait [29]
showed that the most significant difference in teen and parent
scores were among the treatment adherence and worry scales
which is in agreement with our findings. It is believed that this
is due to parental perception of the challenges associated with
lifestyle modifications for their child, as well as parents’
concern for the short and long-term complications diabetes
may have [42]. The known differences in parental and
adolescent’s cognitive development may partly explain this
finding as it is well known that the areas of the brain
responsible for executive functioning, including the ability to
long term plan, make and understand the consequences of
decisions, prioritize, evaluate risk, and regulate behavior, only
develops in the mid 20’s [18].
This is the first study looking at HRQoL in T1DM in
adolescents in Saudi Arabia from both the parent and teen
perspective and assessing the impact the disease has on the
family. The greatest impact on the HRQoL of adolescents with
T1DM and their families in this sample of the population was
worry related to diabetes complications and treatment
effectiveness. Furthermore, the family impact results suggest
that T1DM of adolescents has little impact on family
functioning but may be associated with a negative impact
on parents’ psychological well-being.
Adolescence is sometimes found to be a stressful time in
the life of teens and parents alike because of the major
developmental, hormonal and psychological changes that
occur [18]. T1DM, a disease that involves multiple lifestyle and
psychosocial changes in behavior may further compound an
already dynamic period. Diabetes management must be
tailored to meet specific challenges faced by adolescents.
Systematic review evidence suggests that specialized adoles-
cent health clinics or ‘‘transition clinics’’ are successful in
improving many health outcomes associated with diabetes in
adolescence [43]. Such models should be more widely
considered, with a multidisciplinary care approach to adoles-
cent diabetes care encouraged. This will allow for the holistic
care of adolescents in a developmentally appropriate manner.
Future work could assess the effectiveness of direct care
involvement of dedicated adolescent and mental health
experts in improving the HRQoL for this population.
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